Determinants of functional mitral regurgitation severity in patients with ischemic cardiomyopathy versus nonischemic dilated cardiomyopathy.

Determinants of functional mitral regurgitation severity in patients with ischemic cardiomyopathy versus nonischemic dilated cardiomyopathy.

Mostrar otras versiones (1)

AIMS: Functional mitral regurgitation (MR) is prevalent among patients with left ventricular (LV) dysfunction and is associated with a poorer prognosis. Our aim was to assess the primary determinants of MR severity in patients with ischemic cardiomyopathy (ICM) and nonischemic dilated cardiomyopathy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Konstantinou, D, Papadopoulou, K, Giannakoulas, G, Kamperidis, V, Dalamanga, E, Damvopoulou, E, Parcharidou, D, Karamitsos, T, Karvounis, H
Formato:	Journal article
Lenguaje:	English
Publicado:	2014

Ejemplares similares

Determinants of functional mitral regurgitation severity in patients with ischemic cardiomyopathy versus nonischemic dilated cardiomyopathy
por: Konstantinou, D, et al.
Publicado: (2014)

Differences in echocardiographic characteristics of functional mitral regurgitation in ischaemic versus idiopathic dilated cardiomyopathy: a pilot study.
por: Papadopoulou, K, et al.
Publicado: (2009)

Ischemic versus dilated cardiomyopathy. incremental diagnostic value of Tissue Doppler Imaging
por: Papadopoulou, K, et al.
Publicado: (2006)

Improved papillary muscle function attenuates functional mitral regurgitation in patients with dilated cardiomyopathy after cardiac resynchronization therapy.
por: Karvounis, H, et al.
Publicado: (2006)

The Prognostic Value of Late Gadolinium Enhancement CMR in Nonischemic Cardiomyopathies
por: Karamitsos, T, et al.
Publicado: (2013)

The prognostic value of late gadolinium enhancement CMR in nonischemic cardiomyopathies.
por: Karamitsos, T, et al.
Publicado: (2013)

The current and emerging role of cardiovascular magnetic resonance in the diagnosis of nonischemic cardiomyopathies.
por: Karamitsos, T, et al.
Publicado: (2011)

Dilated cardiomyopathy and the desmin gene.
por: Mayosi, B, et al.
Publicado: (2000)

The prognostic value of late gadolinium enhancement CMR in nonischemic cardiomyopathies topical collection on cardiac PET, CT, and MRI
por: Karamitsos, T, et al.
Publicado: (2013)

Metabolic imaging in dilated cardiomyopathy
por: Neubauer, S
Publicado: (2011)

Hyperubiquitination of proteins in dilated cardiomyopathy.
por: Weekes, J, et al.
Publicado: (2003)

Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy.
por: Tentolouris, C, et al.
Publicado: (2004)

Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy.
por: Lakdawala, N, et al.
Publicado: (2010)

Cardiac Steatosis Detected in Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy and Aortic Stenosis
por: Suttie, J, et al.
Publicado: (2011)

Molecular and genetic dissection of dilated cardiomyopathy
por: Hafizah Khalidh
Publicado: (2015)

Reevaluating the genetic contribution of monogenic dilated cardiomyopathy
por: Mazzarotto, F, et al.
Publicado: (2020)

Recurrence of mitral valve regurgitation after mitral valve repair.
por: Myerson, S
Publicado: (2003)

Obesity modifies the energetic phenotype in dilated cardiomyopathy
por: Rayner, JJ, et al.
Publicado: (2021)

Multiscale technologies for treatment of ischemic cardiomyopathy
por: Mahmoudi, Morteza, et al.
Publicado: (2022)

Multiscale technologies for treatment of ischemic cardiomyopathy
por: Mahmoudi, Morteza, et al.
Publicado: (2021)

Prediction of clinical outcome in asymptomatic mitral regurgitation using CMR
por: D'arcy, J, et al.
Publicado: (2011)

Dilated Cardiomyopathy: Phosphorus 31 MR Spectroscopy at 7 T
por: Stoll, V, et al.
Publicado: (2016)

Quantification of regurgitant fraction in mitral regurgitation by cardiovascular magnetic resonance: comparison of techniques.
por: Kon, M, et al.
Publicado: (2004)

Clinical significance of N-terminal proBrain natriuretic peptide in hypertophic cardiomyopathy
por: Efthimiadis, G, et al.
Publicado: (2006)

Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies.
por: Watkins, H
Publicado: (2003)

Determination of clinical outcome in mitral regurgitation with cardiovascular magnetic resonance quantitation
por: Myerson, S, et al.
Publicado: (2016)

Artificial muscle technology applied towards treating ischemic mitral regurgitation caused by left ventricular remodeling
por: Sabourin, Nicaulas A. (Nicaulas Alexandre), 1978-
Publicado: (2005)

Investigation of a transgenic mouse model of familial dilated cardiomyopathy.
por: Song, W, et al.
Publicado: (2010)

Clinical significance of N-terminal-probrain natriuretic peptide in hypertrophic cardiomyopathy.
por: Efthimiadis, G, et al.
Publicado: (2007)

Regression of dilated-hypokinetic hypertrophic cardiomyopathy by biventricular cardiac pacing.
por: Ashrafian, H, et al.
Publicado: (2007)

Altered Aortic Hemodynamics and Relative Pressure in Patients with Dilated Cardiomyopathy
por: Marlevi, David
Publicado: (2021)

[Abnormal tropomyosin function in ATPase cycle in hypertrophic and dilated cardiomyopathies].
por: Borovikov, I, et al.
Publicado: (2013)

Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy
por: Rayner, JJ, et al.
Publicado: (2020)

MLP and CARP are linked to chronic PKCα signalling in dilated cardiomyopathy
por: Gehmlich, K, et al.
Publicado: (2016)

Percutaneous mitral valve leaflet repair for mitral regurgitation: Interventional procedures guidance [IPG649]
por: National Institute for Health and Care Excellence, CA, et al.
Publicado: (2019)

Autosomal dominant familial dilated cardiomyopathy caused by a novel mutation in phospholamban
por: Carballo, S, et al.
Publicado: (2004)

Cardiomyopathies
por: Chan, K, et al.
Publicado: (2018)

Functional effects of mutations in troponin T and tropomyosin which cause dilated cardiomyopathy
por: Robinson, P, et al.
Publicado: (2003)

Mechanical support in dilated cardiomyopathy: signs of early left ventricular recovery.
por: Westaby, S, et al.
Publicado: (1997)

The role of cardiac energy metabolism and during stress in hypertrophic and dilated cardiomyopathy.
por: Dass, S
Publicado: (2012)